We are live on
!
Find out more
RCM
Requisite Capital Management Portfolio holdings
AUM
$537M
1-Year Est. Return
12.29%
This Fund
S&P 500
This Quarter
Est. Return
-9.86%
1 Year Est. Return
+12.29%
3 Year Est. Return
+31.68%
5 Year Est. Return
+33.85%
10 Year Est. Return
–
AUM
$301M
AUM Growth
-$24.9M
(-7.6%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
89.53%
Holding
85
New
4
Increased
17
Reduced
19
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$34.8M |
| 2 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$17.7M |
| 3 |
Northern Oil and Gas
NOG
|
+$13.4M |
| 4 |
Energy Transfer Partners
ET
|
+$4.51M |
| 5 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$2.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$21.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$4.88M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.68M |
| 4 |
Global X Lithium & Battery Tech ETF
LIT
|
+$4.25M |
| 5 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$3.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.72% |
| 2 | Consumer Discretionary | 2.34% |
| 3 | Technology | 1.63% |
| 4 | Healthcare | 1% |
| 5 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aclaris Therapeutics
ACRS
$750M
| $628K | 0.21% |
+45,000
| New | +$631K |
|
27
Encompass Health
EHC
$11.3B
| $627K | 0.21% |
14,071
| – | – |
|
28
Coinbase
COIN
$44.1B
| $608K | 0.2% |
12,940
+2,455
| +23% | +$234K |
|
29
Johnson & Johnson
JNJ
$641B
| $568K | 0.19% |
3,199
+120
| +4% | +$21.4K |
|
30
Amazon
AMZN
$2.49T
| $527K | 0.18% |
4,960
-140
| -3% | -$17.5K |
|
31
Chevron
CVX
$378B
| $516K | 0.17% |
3,562
-3,360
| -49% | -$555K |
|
32
JPMorgan Chase
JPM
$947B
| $512K | 0.17% |
4,545
+581
| +15% | +$72K |
|
33
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$548M
| $506K | 0.17% |
3,750
| – | – |
|
34
iShares S&P 100 ETF
OEF
$19.8B
| $482K | 0.16% |
2,797
+9
| +0.3% | +$1.68K |
|
35
Alphabet (Google) Class C
GOOG
$3.99T
| $479K | 0.16% |
4,380
-200
| -4% | -$23.6K |
|
36
UnitedHealth
UNH
$379B
| $478K | 0.16% |
930
-550
| -37% | -$276K |
|
37
PUT
Invesco QQQ Trust
QQQ
$449B
| $474K | 0.16% |
15,600
| – | – |
|
38
Altria Group
MO
$122B
| $459K | 0.15% |
10,753
+3,000
| +39% | +$155K |
|
39
Plains GP Holdings
PAGP
$5.16B
| $457K | 0.15% |
44,309
-40,500
| -48% | -$465K |
|
40
British American Tobacco
BTI
$131B
| $417K | 0.14% |
9,722
-3,000
| -24% | -$129K |
|
|
41
iShares MSCI USA Momentum Factor ETF
MTUM
$25.2B
| $405K | 0.13% |
2,971
-147,506
| -98% | -$21.7M |
|
42
Insmed
INSM
$22.7B
| $394K | 0.13% |
20,000
| – | – |
|
43
ConocoPhillips
COP
$141B
| $369K | 0.12% |
4,065
-3,500
| -46% | -$361K |
|
|
44
Alphabet (Google) Class A
GOOGL
$3.99T
| $357K | 0.12% |
3,280
| – | – |
|
|
MAPS
45
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $333K | 0.11% |
615,000
+80,700
| +15% | +$453K |
|
46
Merck
MRK
$323B
| $327K | 0.11% |
3,555
| – | – |
|
47
Madison Square Garden
MSGS
$9.57B
| $302K | 0.1% |
2,000
| – | – |
|
48
ExxonMobil
XOM
$642B
| $276K | 0.09% |
3,218
-4,795
| -60% | -$432K |
|
49
SouthState Bank Corp
SSB
$10.2B
| $254K | 0.08% |
3,295
| – | – |
|
50
Verizon
VZ
$198B
| $243K | 0.08% |
4,780
| – | – |
|
Similar funds
CC
CDR
AFIA
TCOT
HS
BFC
GC
MG
Requisite Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Requisite Capital Management held 85 positions worth $301M, down 7.6% from $326M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Requisite Capital Management deployed $18M of net new capital in Q2 2022, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Aclaris Therapeutics: 45,000 shares worth $628K.
By sector, the portfolio is most concentrated in Energy at 8.7% of assets, up from 5.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $21.7M trimmed.
- Requisite Capital Management's largest Q2 2022 buy was Aclaris Therapeutics: 45,000 shares worth $628K.
- Requisite Capital Management added most to JPMorgan Ultra-Short Income ETF in Q2 2022, an estimated $34.8M increase.
- Requisite Capital Management's biggest Q2 2022 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $21.7M.
- Requisite Capital Management fully exited State Street Energy Select Sector SPDR ETF in Q2 2022, selling an estimated $4.68M.
- Requisite Capital Management's ten largest holdings make up 90% of its $301M portfolio in Q2 2022.
- Requisite Capital Management opened 4 new positions and closed 25 in Q2 2022.
- Requisite Capital Management's portfolio value fell 7.6% quarter-over-quarter to $301M.
Based on Requisite Capital Management's 13F filing for Q2 2022, filed 2 Aug 2022.